6919 — Caliway Biopharmaceuticals Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Caliway Biopharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	93.6	595	1,111	3,712	9,669
Net Total Accounts Receivable
Net Total Receivables	—	—	3.12	7.89	5.18
Total Inventory
Total Other Current Assets
Total Current Assets	111	605	1,132	3,744	9,706
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	115	106	99.6	80.4	61.3
Net Intangible Assets
Other Long Term Assets
Total Assets	227	713	1,233	3,827	9,771
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	64.5	39.7	48.4	73.7	52.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	180	68.2	68.8	85.6	73.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	46.6	645	1,164	3,741	9,697
Total Liabilities & Shareholders' Equity	227	713	1,233	3,827	9,771
Total Common Shares Outstanding